ONC
MODERATEBeOne Medicines Ltd.
CIK: 0001651308
Last activity: 1 weeks ago
Financial Metrics
As of Dec 31, 2024 (10-K)
Insider Roster (4 total, 4 active)
| Insider | Buys | Sells | Net Value | Holdings |
|---|---|---|---|---|
| OYLER JOHN Chief Executive Officer | 0 | 24 | -$30.66M | 10,343 shares $3.13M |
| Wu Xiaobin President and COO | 0 | 3 | -$1.52M | 836 shares $318K |
| Lee Chan Henry SVP, General Counsel | 0 | 5 | -$1.01M | Holdings: - Value: - |
| Sanders Corazon (Corsee) D. DIRECTOR | 0 | 2 | -$896K | 804 shares $274K |
Recent Transactions
996 shares @ $350.00
$349K
Feb 4, 2026
664 shares @ $348.79
$232K
Feb 4, 2026
664 shares @ $331.76
$220K
Jan 7, 2026
7,470 shares @ $302.74
$2.26M
Dec 16, 2025
5,442 shares @ $303.72
$1.65M
Dec 16, 2025
2,567 shares @ $301.79
$775K
Dec 16, 2025
1,973 shares @ $304.36
$601K
Dec 16, 2025
1,877 shares @ $300.80
$565K
Dec 16, 2025
1,633 shares @ $303.13
$495K
Dec 16, 2025
1,512 shares @ $302.31
$457K
Dec 16, 2025
1,255 shares @ $304.13
$382K
Dec 16, 2025
600 shares @ $300.98
$181K
Dec 16, 2025
40 shares @ $305.24
$12K
Dec 16, 2025
16,318 shares @ $310.48
$5.07M
Dec 15, 2025
14,163 shares @ $308.41
$4.37M
Dec 15, 2025
10,650 shares @ $309.37
$3.29M
Dec 15, 2025
6,389 shares @ $302.29
$1.93M
Dec 15, 2025
5,829 shares @ $304.37
$1.77M
Dec 15, 2025
5,118 shares @ $307.38
$1.57M
Dec 15, 2025
4,949 shares @ $306.39
$1.52M
Dec 15, 2025
3,940 shares @ $305.55
$1.20M
Dec 15, 2025
2,344 shares @ $311.33
$730K
Dec 15, 2025
1,896 shares @ $303.60
$576K
Dec 15, 2025
1,791 shares @ $301.58
$540K
Dec 15, 2025
1,194 shares @ $314.92
$376K
Dec 15, 2025
929 shares @ $313.52
$291K
Dec 15, 2025
121 shares @ $311.93
$38K
Dec 15, 2025
332 shares @ $325.00
$108K
Dec 11, 2025
332 shares @ $318.28
$106K
Dec 10, 2025
1,823 shares @ $340.20
$620K
Nov 26, 2025
804 shares @ $342.47
$275K
Nov 26, 2025
3,155 shares @ $380.23
$1.20M
Nov 17, 2025
826 shares @ $381.19
$315K
Nov 17, 2025
10 shares @ $382.32
$4K
Nov 17, 2025
⚠️ Important Disclaimer
• This is AI-generated analysis for educational purposes only, not financial advice.
• Insider trading data is derived from SEC Form 4 filings and may contain errors.
• Always conduct your own research and consult qualified financial advisors before making investment decisions.